RT @BRxAD: Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients https://t.co/6aryty…
RT @BRxAD: Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients https://t.co/6aryty…
RT @BRxAD: Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients https://t.co/6aryty…
RT @BRxAD: Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients https://t.co/6aryty…
RT @BRxAD: Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients https://t.co/6aryty…
RT @BRxAD: Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients https://t.co/6aryty…
Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients https://t.co/6aryty6JL1
RT @hanayukitwin: Intensive Care Med 2016 Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance http…
Intensive Care Med 2016 Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance https://t.co/DqIRnJsXID